Medical Oncology

, Volume 29, Issue 1, pp 48–55

The role of human papillomavirus infection in breast cancer

Review Article

Abstract

Breast cancer is the leading female cancer and the third most common cause of cancer deaths worldwide. Many studies have suggested a possible link between breast cancer pathogenesis and viral infection, particularly mouse mammary tumour virus, simian virus 40, Epstein–Barr virus, and human papillomavirus (HPV). A significant number of recent studies have reported that approximately 29% of human breast cancer tissues were positive for high-risk HPV subtypes, especially HPV subtypes 16, 18, or 33. In contrast, several other investigations did not detect any HPV subtypes in either breast cancer tissue or normal breast tissue from patients diagnosed with breast cancer. Given these conflicting data and the established complexity of the association between HPV with other cancers, a definitive relationship between human breast cancer and HPV infection has not been determined. Recent advances in laboratory methodologies aim to overcome the inherent challenges in detecting HPV in breast cancer tissue. There is an urgent need to obtain additional evidence in order to assess the possibility of breast cancer prevention using HPV vaccines.

Keywords

Human papillomavirus Breast cancer 

Supplementary material

12032_2010_9812_MOESM1_ESM.doc (42 kb)
Supplementary material 1 (DOC 42 kb)
12032_2010_9812_MOESM2_ESM.doc (54 kb)
Supplementary material 2 (DOC 54 kb)
12032_2010_9812_MOESM3_ESM.doc (32 kb)
Supplementary material 3 (DOC 32 kb)

References

  1. 1.
    Amarante MK, Watanabe MA. The possible involvement of virus in breast cancer. J Cancer Res Clin Oncol. 2009;135:329–37.PubMedCrossRefGoogle Scholar
  2. 2.
    Anders CK, Carey LA. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer. 2009;9:S73–81.PubMedCrossRefGoogle Scholar
  3. 3.
    Joshi D, Quadri M, Gangane N, et al. Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS One. 2009;4:e8180.PubMedCrossRefGoogle Scholar
  4. 4.
    Altundag K, Baptista MZ. Human papilloma virus and breast cancer. Br J Cancer. 2006;94:338. author reply 339.PubMedCrossRefGoogle Scholar
  5. 5.
    Melana SM, Nepomnaschy I, Hasa J, et al. Detection of human mammary tumour virus proteins in human breast cancer cells. J Virol Methods. 2010;163:157–61.PubMedCrossRefGoogle Scholar
  6. 6.
    Sifuentes Alvarez A, Reyes Romero M. Risk factors for cervico-uterine cancer associated to HPV: p53 codon 72 polymorphism in women attending hospital care. Ginecol Obstet Mex. 2003;71:12–5.PubMedGoogle Scholar
  7. 7.
    Hausen HZ. Papillomaviruses–to vaccination and beyond. Biochemistry (Mosc). 2008;73:498–503.CrossRefGoogle Scholar
  8. 8.
    Gentschev I, Stritzker J, Hofmann E, et al. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent. Cancer Gene Ther. 2009;16:320–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Buonaguro FM, Tornesello ML, Buonaguro L. Virus-like particle vaccines and adjuvants: the HPV paradigm. Expert Rev Vaccines. 2009;8:1379–98.PubMedCrossRefGoogle Scholar
  10. 10.
    Munger K, Baldwin A, Edwards KM, et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol. 2004;78:11451–60.PubMedCrossRefGoogle Scholar
  11. 11.
    Holly EA. Cervical intraepithelial neoplasia, cervical cancer, and HPV. Annu Rev Public Health. 1996;17:69–84.PubMedCrossRefGoogle Scholar
  12. 12.
    Pizzighella S, Rassu M, Piacentini I, et al. Polymerase chain reaction amplification and restriction enzyme typing as an accurate and simple way to detect and identify human papillomaviruses. J Med Microbiol. 1993;39:33–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Yang L, Mohr I, Fouts E, et al. The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase. Proc Natl Acad Sci U S A. 1993;90:5086–90.PubMedCrossRefGoogle Scholar
  14. 14.
    Rintala MA, Grenman SE, Puranen MH, et al. Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J Clin Microbiol. 2005;43:376–81.PubMedCrossRefGoogle Scholar
  15. 15.
    DiMaio D, Mattoon D. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene. 2001;20:7866–73.PubMedCrossRefGoogle Scholar
  16. 16.
    Howley PM, Munger K, Werness BA, et al. Molecular mechanisms of transformation by the human papillomaviruses. Princess Takamatsu Symp. 1989;20:199–206.PubMedGoogle Scholar
  17. 17.
    Scheffner M, Huibregtse JM, Vierstra RD, et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993;75:495–505.PubMedCrossRefGoogle Scholar
  18. 18.
    Dyson N, Howley PM, Munger K, et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Dyson N, Guida P, Munger K, et al. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol. 1992;66:6893–902.PubMedGoogle Scholar
  20. 20.
    Stubenrauch F, Laimins LA. Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol. 1999;9:379–86.PubMedCrossRefGoogle Scholar
  21. 21.
    Centers for Disease Control and Prevention. Human papillomavirus: HPV information for clinicians. Ala Nurse. 2008;35:17–9.Google Scholar
  22. 22.
    zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–50.PubMedCrossRefGoogle Scholar
  23. 23.
    Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003;89:101–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Nemes JA, Deli L, Nemes Z, et al. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:344–52.PubMedCrossRefGoogle Scholar
  25. 25.
    Crum CP, McLachlin CM, Tate JE, et al. Pathobiology of vulvar squamous neoplasia. Curr Opin Obstet Gynecol. 1997;9:63–9.PubMedGoogle Scholar
  26. 26.
    Klencke BJ, Palefsky JM. Anal cancer: an HIV-associated cancer. Hematol Oncol Clin North Am. 2003;17:859–72.PubMedCrossRefGoogle Scholar
  27. 27.
    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 1995;64:1–378.Google Scholar
  28. 28.
    Teitelman AM, Stringer M, Averbuch T, et al. Human papillomavirus, current vaccines, and cervical cancer prevention. J Obstet Gynecol Neonatal Nurs. 2009;38:69–80.PubMedCrossRefGoogle Scholar
  29. 29.
    Rylander E, Ruusuvaara L, Almstromer MW, et al. The absence of vaginal human papillomavirus 16 DNA in women who have not experienced sexual intercourse. Obstet Gynecol. 1994;83:735–7.PubMedGoogle Scholar
  30. 30.
    Sawaya GF, Smith-McCune K. HPV vaccination–more answers, more questions. N Engl J Med. 2007;356:1991–3.PubMedCrossRefGoogle Scholar
  31. 31.
    Revzina NV, Diclemente RJ. Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review. Int J STD AIDS. 2005;16:528–37.PubMedCrossRefGoogle Scholar
  32. 32.
    Baldwin P, Laskey R, Coleman N. Translational approaches to improving cervical screening. Nat Rev Cancer. 2003;3:217–26.PubMedCrossRefGoogle Scholar
  33. 33.
    Winer RL, Lee SK, Hughes JP, et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157:218–26.PubMedCrossRefGoogle Scholar
  34. 34.
    Lipskie TL. A summary of cancer screening guidelines. Chronic Dis Can. 1998;19:112–30.PubMedGoogle Scholar
  35. 35.
    Rambout L, Hopkins L, Hutton B, et al. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ. 2007;177:469–79.PubMedCrossRefGoogle Scholar
  36. 36.
    de León DC, Montiel DP, Nemcova J, et al. Human papillomavirus (HPV) in breast tumours: prevalence in a group of Mexican patients. BMC Cancer. 2009;9:26.PubMedCrossRefGoogle Scholar
  37. 37.
    Di Lonardo A, Venuti A, Marcante ML. Human papillomavirus in breast cancer. Breast Cancer Res Treat. 1992;21:95–100.PubMedCrossRefGoogle Scholar
  38. 38.
    Hennig EM, Suo Z, Thoresen S, et al. Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat. 1999;53:121–35.PubMedCrossRefGoogle Scholar
  39. 39.
    Hennig EM, Kvinnsland S, Holm R, et al. Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas. Acta Oncol. 1999;38:931–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Yu Y, Morimoto T, Sasa M, et al. Human papillomavirus type 33 DNA in breast cancer in Chinese. Breast Cancer. 2000;7:33–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Liu Y, Klimberg VS, Andrews NR, et al. Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol. 2001;4:329–34.PubMedGoogle Scholar
  42. 42.
    Damin AP, Karam R, Zettler CG, et al. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat. 2004;84:131–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Widschwendter A, Brunhuber T, Wiedemair A, et al. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol. 2004;31:292–7.PubMedCrossRefGoogle Scholar
  44. 44.
    de Villiers EM, Sandstrom RE, zur Hausen H, et al. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res. 2005;7:R1–11.PubMedCrossRefGoogle Scholar
  45. 45.
    Kan CY, Iacopetta BJ, Lawson JS, et al. Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer. 2005;93:946–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Kroupis C, Markou A, Vourlidis N, et al. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem. 2006;39:727–31.PubMedCrossRefGoogle Scholar
  47. 47.
    Gumus M, Yumuk PF, Salepci T, et al. HPV DNA frequency and subset analysis in human breast cancer patients’ normal and tumoural tissue samples. J Exp Clin Cancer Res. 2006;25:515–21.PubMedGoogle Scholar
  48. 48.
    Damin AP, Damin DC, Alexandre CO. HPV infection and breast cancer. Breast. 2007;16:222.PubMedCrossRefGoogle Scholar
  49. 49.
    Yasmeen A, Bismar TA, Kandouz M, et al. E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle. 2007;6:2038–42.PubMedCrossRefGoogle Scholar
  50. 50.
    Kulka J, Kovalszky I, Svastics E, et al. Lymphoepithelioma-like carcinoma of the breast: not Epstein-Barr virus-, but human papilloma virus-positive. Hum Pathol. 2008;39:298–301.PubMedCrossRefGoogle Scholar
  51. 51.
    Sarkola M, Rintala M, Grenman S, et al. Human papillomavirus DNA detected in breast milk. Pediatr Infect Dis J. 2008;27:557–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Akil N, Yasmeen A, Kassab A, et al. High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Br J Cancer. 2008;99:404–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Heng B, Glenn WK, Ye Y, et al. Human papilloma virus is associated with breast cancer. Br J Cancer. 2009;101:1345–50.PubMedCrossRefGoogle Scholar
  54. 54.
    Bratthauer GL, Tavassoli FA, O’Leary TJ. Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract. 1992;188:384–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Wrede D, Luqmani YA, Coombes RC, et al. Absence of HPV 16 and 18 DNA in breast cancer. Br J Cancer. 1992;65:891–4.PubMedCrossRefGoogle Scholar
  56. 56.
    Gopalkrishna V, Singh UR, Sodhani P, et al. Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat. 1996;39:197–202.PubMedCrossRefGoogle Scholar
  57. 57.
    Lindel K, Forster A, Altermatt HJ, et al. Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast. 2007;16:172–7.PubMedCrossRefGoogle Scholar
  58. 58.
    de Cremoux P, Thioux M, Lebigot I, et al. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat. 2008;109:55–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Khan NA, Castillo A, Koriyama C, et al. Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer. 2008;99:408–14.PubMedCrossRefGoogle Scholar
  60. 60.
    Mendizabal-Ruiz AP, Morales JA, Ramirez-Jirano LJ, et al. Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat. 2009;114:189–94.PubMedCrossRefGoogle Scholar
  61. 61.
    Choi YL, Cho EY, Kim JH, et al. Detection of human papillomavirus DNA by DNA chip in breast carcinomas of Korean women. Tumour Biol. 2007;28:327–32.PubMedCrossRefGoogle Scholar
  62. 62.
    Branca M, Ciotti M, Giorgi C, et al. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2007;130:223–31.PubMedCrossRefGoogle Scholar
  63. 63.
    zur Hausen H. Human papillomavirus & cervical cancer. Indian J Med Res. 2009;130:209.PubMedGoogle Scholar
  64. 64.
    Vonka V. Causality in medicine: the case of tumours and viruses. Philos Trans R Soc Lond B Biol Sci. 2000;355:1831–41.PubMedCrossRefGoogle Scholar
  65. 65.
    Lawson JS. Do viruses cause breast cancer? Methods Mol Biol. 2009;471:421–38.PubMedCrossRefGoogle Scholar
  66. 66.
    Liang W, Tian H. Hypothetic association between human papillomavirus infection and breast carcinoma. Med Hypotheses. 2008;70:305–7.PubMedCrossRefGoogle Scholar
  67. 67.
    Anhang R, Goodman A, Goldie SJ. HPV communication.review of existing research and recommendations for patient education. CA Cancer J Clin. 2004;54:248–59.PubMedCrossRefGoogle Scholar
  68. 68.
    zur Hausen H. The search for infectious causes of human cancers: where and why (Nobel lecture). Angew Chem Int Ed Engl. 2009;48:5798–808.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Ting Wang
    • 1
  • Peng Chang
    • 1
  • Ling Wang
    • 1
  • Qing Yao
    • 1
  • Wen Guo
    • 1
  • Jianghao Chen
    • 1
  • Tristan Yan
    • 2
  • Christopher Cao
    • 2
  1. 1.Department of Vascular and Endocrine Surgery, Xijing HospitalFourth Military Medical UniversityXi’anChina
  2. 2.Department of Cardiothoracic SurgeryThe Baird Institute for Applied Heart and Lung Surgical Research and The Royal Prince Alfred HospitalSydneyAustralia

Personalised recommendations